| |
|
|
Korea United Pharm. Inc. (033270) |
|
|
STOCK |
|
|
|
  |
(unit : Won, Share) |
| Fiscal Year End |
06.03 | 07.03 | 07.12 | 08.03 |
| Par Value |
500 | 500 | 500 | 500 |
| Yearly Highest Price |
2,800 | 4,060 | 4,480 | 3,450 |
| Yearly Lowest Price |
1,410 | 1,825 | 3,030 | 2,800 |
| Common Shares O/S |
15,025,924 | 15,025,924 | 15,025,924 | 15,025,924 |
| Preferred Shares O/S |
- | - | - | - |
| Market Cap.(100Mn.Won) |
370 | 596 | 491 | 489 |
| Dividends (%) |
10.0 | 10.0 | 10.0 | - |
|
 |
(Company/Sector/Market) |
| |
2006.12 | 2007.12 |
| Beta |
- /- /- | 0.58 / 0.75 / 1.00 |
| Volatility |
- /- /- | 36.67 / 24.30 / 22.80 |
|
 |
(unit : Won) |
| Fiscal Year End |
06.03 | 07.03 | 07.12 | 08.03 |
| Earnings Per Share |
58 | 272 | 380 | 744 |
| Sales Per Share |
3,920 | 4,648 | 4,065 | 6,262 |
| Book Value Per Share |
2,378 | 2,570 | 2,913 | 3,055 |
| Cash Flow Per Share |
399.35 | 670.38 | 231.77 | - 42.57 |
|
 |
(Unit : Times) |
| Fiscal Year End |
06.03 | 07.03 | 07.12 | 08.03 |
| Price / Earnings (H/L) |
48.28/24.31 | 14.93/6.71 | 11.79/7.97 | 4.64/3.76 |
| Price / Sales (H/L) |
0.71/0.36 | 0.87/0.39 | 1.10/0.75 | 0.55/0.45 |
| Price / Book (H/L) |
1.18/0.59 | 1.58/0.71 | 1.54/1.04 | 1.13/0.92 |
| Price / Cash Flow (H/L) |
7.01 / 3.53 | 6.06 / 2.72 | 19.33 / 13.07 | - /- |
|
 |
(Unit : 100Mn.Won, %) |
| Fiscal Year End |
05.03 |
06.03 |
07.03 |
07.12 |
| Company |
Sector |
Company |
Sector |
Company |
Sector |
Company |
Sector |
| Invested Capital |
514 |
501 |
514 |
480 |
512 |
524 |
533 |
544 |
| NOPLAT |
20 |
38 |
35 |
36 |
66 |
35 |
56 |
47 |
| Return on Invested Capital |
4 |
9 |
6 |
9 |
12 |
7 |
10 |
9 |
| WACC |
5 |
5 |
6 |
6 |
6 |
7 |
5 |
6 |
| Economic Value Added |
- 9.4 |
10.6 |
1.9 |
7.3 |
31.3 |
3.9 |
24.3 |
11.8 |
|
 |
(Unit : 100Mn.Won, Times) |
| Fiscal Year End |
2006.03 | 2007.03 | 2007.12 | 2008.03 |
| Enterprise Value(EV) |
556.40 | 744.79 | 648.14 | 652.88 |
| EBITDA |
75.43 | 103.00 | 96.86 | 168.32 |
| EBITDA/Sales |
0.13 | 0.15 | 0.16 | 0.18 |
| EBITDA/Financial Exp. |
4.83 | 5.58 | 7.41 | 9.41 |
| EV/EBITDA |
7.38 | 7.23 | 6.69 | 3.88 |
|
|
|
|
